Cesarean Section
Conditions
Interventions
Midazolam:intravenously midazolam (0.02mg kg-1) 20mL
dexmedetomidine:intravenously dexmedetomidine (1ug kg-1) 20mL
Sponsors
Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. women aged 20-40 years; 2. need to be treated with hemabate intraoperatively; 3. patients who were arranged to undergo scheduled cesarean section under epidural anesthesia.
Exclusion criteria
Exclusion criteria: 1. long-term opioid pain relieving utilization or NSAIDs, sedative utilization, mental illnesses; 2. preoperative heart rate (HR) lower than 50bpm with atrial-ventricular conduction abnormalities or rhythm irregularities, neuromuscular and endocrine sicknesses; 3. hypersensitive reactions to a2-adrenergic receptor agonists; 4. There are contraindications to epidural anesthesia,such as coagulation disfunction,local anesthetic allergy etc; 5. with severe heart,kindey,liver or respiratory diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea;vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| headache;headache;chest congestion;facial flushing;satisfaction score;Ramsay score;BIS score;1 min, 5 min, 10 min and 30 min vital signs after hemabate injection; | — |
Countries
China
Contacts
Public ContactBailong Hu
The Affiliated Hospital of Guizhou Medical University
Outcome results
None listed